IPA.V
Immunoprecise Antibodies Ltd
Price:  
6.50 
CAD
Volume:  
6,200.00
Canada | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IPA.V Probability of Bankruptcy

The Probability of Bankruptcy of Immunoprecise Antibodies Ltd (IPA.V) is -% . This number represents the probability that IPA.V will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating IPA.V's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

IPA.V - ESG ratings

ESG ratings are directly linked to the cost of capital and IPA.V's ability to raise funding, both of which can significantly affect the probability of Immunoprecise Antibodies Ltd going bankrupt.

ESG Score -
Environment Score -
Social Score -
Governance Score -
Returns
Historical Returns (5 day) -5.15%
Historical Returns (MTD) -1.64%
Historical Returns (YTD) 4.21%
Historical Returns (13 week) -8.88%
Historical Returns (26 week) -9.11%
Historical Returns (52 week) -40.81%
Efficiency
Asset Turnover 0.38
Receiveable Turnover 4.88
Gross Margin 54.96%
Operating Margin -79.33%
Pretax Margin -81.52%
Net Margin -89.98%
Return on Asset (ROA)
Return on Equity (ROE) -34.18
Return on Investments (ROI) -39.91
Price Metrics
Market Cap (M) 129.87
Enterprise Value (M)
52 Week High 20.20
52 Week Low 4.52
Beta -0.23
Average Volume (10 day) 0.02
Average Volume (3 month) 0.65
Price / Earnings (P/E)
Price / Sales (P/S) 7.65
Earnings
EPS
Revenue CAGR (5 year)
Risk
Current Ratio 5.68
Quick Ratio